Vaccine
US6040427A · kind A · utility
13Cited by
13References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 1998 |
| Grant date | Mar 21, 2000 |
| Priority date | — |
| Expiry date | Jul 1, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The Bordetella pertussis toxin is genetically modified to express a toxin protein which is deficient in target-cell receptor binding and is used in a vaccine for protection against whooping cough.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.